These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34176289)

  • 21. Potent antiretroviral therapy for human immunodeficiency virus infection increases aortic stiffness.
    Eira M; Bensenor IM; Dorea EL; Cunha RS; Mill JG; Lotufo PA
    Arq Bras Cardiol; 2012 Dec; 99(6):1100-7. PubMed ID: 23197168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The concomitant use of second-generation antipsychotics and long-term antiretroviral therapy may be associated with increased cardiovascular risk.
    Ferrara M; Umlauf A; Sanders C; Meyer JM; Allen McCutchan J; Duarte N; Hampton Atkinson J; Grant I; Ellis RJ;
    Psychiatry Res; 2014 Aug; 218(1-2):201-8. PubMed ID: 24794030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenesis and clinical implications of HIV-related anemia in 2013.
    Redig AJ; Berliner N
    Hematology Am Soc Hematol Educ Program; 2013; 2013():377-81. PubMed ID: 24319207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Yes, simplify antiretroviral treatments, but not at a significant price!].
    Casalino E
    Med Mal Infect; 2005 Apr; 35 Suppl 1():S11-4. PubMed ID: 15922875
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of antiretroviral therapy on arterial stiffness in Cameroonian HIV-infected patients.
    Ngatchou W; Lemogoum D; Ndobo P; Yiagnigni E; Tiogou E; Nga E; Kouanfack C; Nde F; Degaute JP; van de Borne P; Leeman M
    Blood Press Monit; 2013 Oct; 18(5):247-51. PubMed ID: 23873153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelial function and cardiovascular diseases in HIV infected patient.
    Andrade AC; Cotter BR
    Braz J Infect Dis; 2006 Apr; 10(2):139-45. PubMed ID: 16878266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV infection and cardiovascular disease--is there really a link?
    Sklar P; Masur H
    N Engl J Med; 2003 Nov; 349(21):2065-7. PubMed ID: 14627792
    [No Abstract]   [Full Text] [Related]  

  • 28. HIV and Cardiovascular Disease: Role of Immunometabolic Perturbations.
    Teer E; Essop MF
    Physiology (Bethesda); 2018 Jan; 33(1):74-82. PubMed ID: 29212894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New antiretroviral drugs and approaches to HIV treatment.
    Paredes R; Clotet B
    AIDS; 2003; 17 Suppl 4():S85-96. PubMed ID: 15080184
    [No Abstract]   [Full Text] [Related]  

  • 30. Antiretroviral drugs and liver injury.
    Soriano V; Puoti M; Garcia-Gascó P; Rockstroh JK; Benhamou Y; Barreiro P; McGovern B
    AIDS; 2008 Jan; 22(1):1-13. PubMed ID: 18090386
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluating and managing cardiovascular disease risk factors in HIV-infected patients.
    Top HIV Med; 2010 Dec; 18(5):164-8. PubMed ID: 21245517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aggressive worsening of Sézary syndrome during early antiretroviral therapy.
    Lehloenya RJ; Shebe K; Hlela C; Dlamini S; Mankahla A; Lapiner V; Meintjes G; Todd G
    AIDS; 2013 Mar; 27(6):1035-1036. PubMed ID: 23698068
    [No Abstract]   [Full Text] [Related]  

  • 33. The effects of CD4 nadirs on vessel stiffness in HIV patients undergoing antiretroviral therapy.
    Mikuła T; Balsam P; Peller M; Suchacz M; Puchalski B; Kołtowski Ł; Maciejewski K; Wiercińska-Drapało A; Opolski G; Filipiak KJ
    Kardiol Pol; 2017; 75(8):749-757. PubMed ID: 28553846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Is there an increased risk for cardiovascular disease in HIV-infected patients on antiretroviral therapy?].
    Duong M; Cottin Y; Froidure M; Petit JM; Piroth L; Zeller M; L'huillier I; Fargeot A; Mahrousseh M; Chavanet P; Wolf JE; Portier H
    Ann Cardiol Angeiol (Paris); 2003 Nov; 52(5):302-7. PubMed ID: 14714344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CROI 2016: Complications of HIV Infection and Antiretroviral Therapy.
    Havlir DV; Currier JS
    Top Antivir Med; 2016; 24(1):38-46. PubMed ID: 27398861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiretroviral therapy and management of HIV infection.
    Volberding PA; Deeks SG
    Lancet; 2010 Jul; 376(9734):49-62. PubMed ID: 20609987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Case files from the Bellevue Hospital Center at New York University--lipoatrophy following long-term antiretroviral therapy.
    Daskalakis D; Aberg JA
    MedGenMed; 2005 Oct; 7(4):9. PubMed ID: 16614631
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiovascular risks of antiretroviral therapies.
    Mondy K; Tebas P
    Annu Rev Med; 2007; 58():141-55. PubMed ID: 17217329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiretroviral drugs in HIV-infected children.
    Viganò A; Manfredini V; Penagini F; Giacomet V; Zuccotti GV
    Pharmacol Res; 2011 Jul; 64(1):1-3. PubMed ID: 21255650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular risk and dyslipidemia management in HIV-infected patients.
    Stein JH
    Top Antivir Med; 2012; 20(4):129-33; quiz 123-4. PubMed ID: 23154252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.